Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes
570
Green Fluorescent Proteins
Molecular Sequence Data
610
610 Medicine & health
Article
Cell Line
Consanguinity
1311 Genetics
Animals
Humans
Abnormalities, Multiple
Genetic Predisposition to Disease
Amino Acid Sequence
Cilia
In Situ Hybridization
Microscopy, Confocal
Base Sequence
Gastrulation
Gene Expression Regulation, Developmental
Membrane Proteins
BARDET BIEDL SYNDROME; PLANAR CELL POLARITY; GRUBER SYNDROME; ACTIN CYTOSKELETON RENAL SYNDROME; GENE; PROTEINS; CILIARY; DISSECTION; MECHANISMS
Embryo, Mammalian
Pedigree
10036 Medical Clinic
Jews
Mutation
DOI:
10.1038/ng.594
Publication Date:
2010-05-30T19:43:27Z
AUTHORS (51)
ABSTRACT
Joubert syndrome (JBTS), related disorders (JSRDs) and Meckel syndrome (MKS) are ciliopathies. We now report that MKS2 and CORS2 (JBTS2) loci are allelic and caused by mutations in TMEM216, which encodes an uncharacterized tetraspan transmembrane protein. Individuals with CORS2 frequently had nephronophthisis and polydactyly, and two affected individuals conformed to the oro-facio-digital type VI phenotype, whereas skeletal dysplasia was common in fetuses affected by MKS. A single G218T mutation (R73L in the protein) was identified in all cases of Ashkenazi Jewish descent (n=10). TMEM216 localized to the base of primary cilia, and loss of TMEM216 in mutant fibroblasts or after knockdown caused defective ciliogenesis and centrosomal docking, with concomitant hyperactivation of RhoA and Dishevelled. TMEM216 formed a complex with Meckelin, which is encoded by a gene also mutated in JSRDs and MKS. Disruption of tmem216 expression in zebrafish caused gastrulation defects similar to those in other ciliary morphants. These data implicate a new family of proteins in the ciliopathies and further support allelism between ciliopathy disorders.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (243)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....